Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
High-density Lipoprotein Cholesterol (HDL-C)
100%
Psoriasis
100%
Apolipoprotein E
75%
Anti-HDL Antibodies
62%
Apolipoprotein A-I (ApoA-I)
50%
Interleukin-6
25%
Cardiovascular Risk
25%
Paraoxonase 1 (PON1)
25%
Biological Variables
25%
Clinical Data
12%
Therapeutic Approaches
12%
High Titer
12%
Regression Analysis
12%
Epidemiological Data
12%
Immunoassay
12%
Healthy Controls
12%
High-density Lipoprotein Function
12%
Titer
12%
Vascular Cell Adhesion molecule-1 (VCAM-1)
12%
Disease Severity
12%
Clinical Variables
12%
Inflammatory Immune Response
12%
Prevention Approaches
12%
Chronic Inflammatory Diseases
12%
Moderate-to-severe Psoriasis
12%
Immune Disorders
12%
Antibody IgG
12%
Immunology and Microbiology
High-Density Lipoprotein
100%
Apolipoprotein E
100%
Atherosclerosis
50%
Apolipoprotein
50%
Titer
33%
Interleukin 6
33%
Tumor Necrosis Factor
16%
ELISA
16%
Immunoglobulin G
16%
Immunoglobulin M
16%
VCAM-1
16%
Immunoassay
16%
Immune System Disorders
16%
Anti-Apolipoprotein Antibodies
16%
Biochemistry, Genetics and Molecular Biology
High-Density Lipoprotein
100%
Apolipoprotein E
100%
Apolipoprotein
50%
Paraoxonase
33%
Aryldialkylphosphatase
33%
Titer
33%
Interleukin 6
33%
Immunoglobulin G
16%
VCAM-1
16%
Tumor Necrosis Factor
16%
Immunoassay
16%
Immunoglobulin M
16%
Anti-Apolipoprotein Antibodies
16%